Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06178315 · ClinicalTrials.gov registry record · NA
EUS-guided Celiac Plexus Block vs. Sham in Chronic Pancreatitis
A NA study of Chronic Pancreatitis, sponsored by Orlando Health.
- Recruiting
- Registry status
- NA
- Development phase
- 94
- Enrollment target
- 1
- Study location
NCT06178315: Recruiting NA study of Chronic Pancreatitis, sponsored by Orlando Health.
NCT06178315 is a NA study of Chronic Pancreatitis that is actively recruiting participants, run by Orlando Health. The registered enrollment target is 94 participants, below the 687-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06178315, a NA study of Chronic Pancreatitis, is actively recruiting participants, sponsored by Orlando Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this randomized trial is to assess the efficacy of EUS-CPB in the alleviation of abdominal pain in patients with chronic pancreatitis.
Primary Outcome
Rate of adequate pain relief in patients with chronic pancreatitis undergoing endoscopic ultrasound-guided celiac plexus block or sham procedure. Adequate pain relief is defined as a 50% reduction in composite pain score from baseline, measured using the Brief Pain Inventory-Short Form, at 1 month post-intervention.
Conditions Studied
Interventions
- PROCEDURE Sham procedure
- PROCEDURE EUS-guided celiac plexus block
Study Locations (1)
Florida
- Orlando Health - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2023-12-07 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06178315 shows while recruiting
NCT06178315 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 687-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Chronic Pancreatitis appearing as the primary indexed condition, and to 2 interventions - of which Sham procedure is the first listed.
NCT06178315 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06178315 about?
NCT06178315 is a clinical study titled "EUS-guided Celiac Plexus Block vs. Sham in Chronic Pancreatitis". The aim of this randomized trial is to assess the efficacy of EUS-CPB in the alleviation of abdominal pain in patients with chronic pancreatitis.
What is the current status of trial NCT06178315?
This trial is currently recruiting. It is a NA study. The enrollment target is 94 participants. The study started on 2023-12-07. Estimated completion is 2026-12-31.
What conditions does trial NCT06178315 study?
This clinical trial studies the following conditions: Chronic Pancreatitis.
What interventions are being tested in trial NCT06178315?
The interventions under investigation include: Sham procedure (PROCEDURE), EUS-guided celiac plexus block (PROCEDURE).
Who is sponsoring clinical trial NCT06178315?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06178315 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06178315's enrollment target sits among peer trials
94 17th of 42 higher than 26 of 42 other Chronic Pancreatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Scrambler Therapy in Chronic Pancreatitis
RECRUITING · NA
-
Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis
RECRUITING · NA
-
QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing
RECRUITING · NA
-
Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain
RECRUITING · NA
-
A Tailored, Web-Based Self-Management Program to Treat Pain in Chronic Pancreatitis
ACTIVE NOT RECRUITING · NA
-
Endoscopic Ultrasound Compared With Pancreatic Function Testing for Diagnosis of Chronic Pancreatitis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI